| Product NDC: | 0378-3288 |
| Proprietary Name: | Etidronate Disodium |
| Non Proprietary Name: | etidronate disodium |
| Active Ingredient(s): | 400 mg/1 & nbsp; etidronate disodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0378-3288 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075800 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120507 |
| Package NDC: | 0378-3288-91 |
| Package Description: | 60 TABLET in 1 BOTTLE, PLASTIC (0378-3288-91) |
| NDC Code | 0378-3288-91 |
| Proprietary Name | Etidronate Disodium |
| Package Description | 60 TABLET in 1 BOTTLE, PLASTIC (0378-3288-91) |
| Product NDC | 0378-3288 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | etidronate disodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120507 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | ETIDRONATE DISODIUM |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |